FDA NDC Directory · JSON-LD · Markdown
NDC 0228-3116 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Actavis Pharma, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA079040 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | MORPHINE SULFATE (45 mg/1) |
| Marketing started | 20140204 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).